1.. Traumatic events, PTSD and coping {#S0001}
=====================================

Whereas acute stress reactions are fairly common after experiencing a traumatic event, characterized by exposure to actual or threatened death, serious injury or sexual violence (American Psychiatric Association, [2013](#CIT0001)), only a minority of exposed individuals will suffer long-term consequences such as posttraumatic stress disorder (PTSD) or other trauma-associated symptoms. Numbers on exposure to at least one traumatic event vary and can reach a prevalence of over 70% worldwide (Benjet et al., [2016](#CIT0004)). Influenced by varying pre-, peri-, and posttraumatic factors, about 10% of those develop a clinical PTSD (Breslau, [2009](#CIT0010)), with symptoms such as intrusive memories, hyperarousal, avoidance behaviour and changes in cognition and mood (American Psychiatric Association, [2013](#CIT0001)). According to meta-analytic data, about 44% of the individuals suffering from PTSD experience spontaneous remission (Morina, Wicherts, Lobbrecht, & Priebe, [2014](#CIT0035)). Of those seeking treatment, however, up to 54% do not respond to or drop out of care (Bradley, Greene, Russ, Dutra, & Westen, [2005](#CIT0009); Najavits, [2015](#CIT0037)). This heterogeneity shows the relevance of individual factors for development and maintenance of PTSD. Therefore, research on factors leading to less severe pathogenesis as well as enhancing remission, such as individual coping, is crucial for progress in PTSD therapy.

One major progress in psychological research is the possibility to examine underlying biological mechanisms of psychopathology, enabling researchers to further explore disease mechanisms, but also future treatment options. In PTSD, a current focus is on the so-called 'stress hormone' cortisol and other parameters associated with the hypothalamic-pituitary-adrenal (HPA) axis central for the endocrine stress response (Olff, Langeland, & Gersons, [2005](#CIT0039); Olff & van Zuiden, [2017](#CIT0040); Steudte-Schmiedgen, Kirschbaum, Alexander, & Stalder, [2016](#CIT0055); van Zuiden et al., [2019](#CIT0060)). While the assessment of cortisol levels is possible in urine, saliva, or blood, these measures reflect a rather short time span of HPA axis activity with higher variability due to situational influences. Over the past decade, analysis of hair cortisol concentrations (HCC) has thus been successfully implemented as a valid and reliable marker of cumulative, long-term cortisol secretion (Stalder & Kirschbaum, [2012](#CIT0053)). Although due to the method's novelty, no normative values are available so far, its aptness for longitudinal research questions has greatly increased the feasibility of examining psychopathology (Stalder & Kirschbaum, [2012](#CIT0053)). One main insight from HCC in the context of PTSD and trauma research is the assumption of a characteristic time course of cortisol secretion in response to trauma, namely elevated levels immediately after traumatization and a down-regulation with increasing time since the traumatic event (i.e. hypocortisolism; Steudte-Schmiedgen et al., [2016](#CIT0055)). Notably, those processes do not seem to be constrained to psychopathologies after traumatic events, but were also shown, albeit less pronounced, in individuals who had experienced traumatic events without having developed PTSD (e.g. Steudte et al., [2013](#CIT0054)). Associations of lower HCC have further been found with more severe intrusion (e.g. Steudte et al., [2013](#CIT0054)) and avoidance symptoms (e.g. Steudte-Schmiedgen et al., [2015](#CIT0056); Wang et al., [2015](#CIT0062)).

However, as existing studies so far mostly focused on pathogenetic facets in PTSD, associations of endocrine markers with more salutogenic perspectives on factors contributing to less severe symptomatology or quicker and more stable remission remained largely neglected.

'Although it has proven difficult to document unequivocally, coping research argues that how people deal with stress can reduce or amplify the effects of adverse life events and conditions ... ' (Skinner, Edge, Altman, & Sherwood, [2003](#CIT0049)). Coping with the traumatic experience itself, but also with trauma sequelae like PTSD symptoms plays an important role in several influential PTSD models (Foa, Hembree, & Rothbaum, [2007](#CIT0021)), most clearly in the 'Cognitive Model of PTSD' (Ehlers & Clark, [2000](#CIT0018)). According to this framework, strategies like, e.g. avoidance, self-medication, and safety behaviour in reaction to symptom experiencing have an adverse influence on the course of illness (Brewin & Holmes, [2003](#CIT0011); Ehlers & Clark, [2000](#CIT0018)). Moreover, the most common and arguably most adverse way of coping with PTSD symptoms, avoidance, is reflected in the diagnostic criteria for PTSD (American Psychiatric Association, [2013](#CIT0001)), and is also the focus of therapeutic interventions, e.g. in Prolonged Exposure (Foa et al., [2007](#CIT0021)), making it both a central PTSD symptom and a factor contributing to the maintenance of symptomatology (Foa & Kozak, [1986](#CIT0022)).

While there are important data on coping with PTSD symptomatology (Clohessy & Ehlers, [1999](#CIT0015); Dempsey, Stacy, & Moely, [2000](#CIT0016); Hassija, Garvert, & Cloitre, [2015](#CIT0029); Olff et al., [2005](#CIT0039); Street, Gibson, & Holohan, [2005](#CIT0057); Sullivan, Weiss, Price, Pugh, & Hansen, [2018](#CIT0059)), their interpretation is limited by the purely retrospective character of assessing coping strategies. Capturing detailed intra-individual fluctuations free from the impact of biases caused by retrospective recall (Schwarz, [2012](#CIT0048);) is often impossible, limiting the ecological validity of those results. Well-known effects are, e.g. generalization bias, context, primacy or recency effects or the influence of later events on recall (Smyth & Stone, [2003](#CIT0050)). Additionally, symptoms of and coping with PTSD are considered to fluctuate over time. All this underlines the necessity to turn to novel methods in order to enrich traditional, retrospective self-report.

2.. Ecological momentary assessment (EMA) and the network approach {#S0002}
==================================================================

EMA is a research tool that collects data in an ambulatory fashion in participants' natural environments, usually via smartphones. In recent years, especially with the advance of mobile technology that allowed for the extended collection of EMA data, many interesting studies have been published proving the feasibility of the method in clinical research and giving insights into the dynamics of psychological conditions following traumatization (Gaher et al., [2014](#CIT0024); Pfaltz, Michael, Grossman, Margraf, & Wilhelm, [2010](#CIT0041); Possemato et al., [2012](#CIT0042); Walz, Nauta, & Aan Het Rot, [2014](#CIT0061)). However, research has yet to make the most of the novel technologies by, on the one hand, combining innovative self-report like EMA with newly-quantifiable endocrine correlates of PTSD and, on the other, to draw on the full potential of EMA by applying innovative statistical approaches.

Prominently, network analyses have gained much popularity in psychological science by adding new approaches to classical disease models. Here, the understanding of psychopathology differs in some aspects from the traditional views (for two reviews, see Fried et al., [2017](#CIT0023); McNally, [2016](#CIT0034)), mainly put forward by Borsboom and colleagues (e.g. Borsboom & Cramer, [2013](#CIT0008)). They postulate that psychopathological episodes do not necessarily covariate due to an underlying latent variable, but rather 'emerge\[s\] from the dynamic, causal interactions among symptoms themselves' (McNally, [2016](#CIT0034), p. 1). Thus, an episode of a disorder is explained by activation of a number of highly interconnected symptoms. Targeting central symptoms or their links to other symptoms (e.g. by therapeutic intervention) may cause deactivation and thus lead to recovery (McNally, [2016](#CIT0034)). Comorbidities are explained by the model through the introduction of the so-called bridge symptoms (Fried et al., [2017](#CIT0023)). For instance, Robinaugh and colleagues identified a feeling that life is empty or meaningless as well as loneliness to be bridge symptoms that influence both depression and persistent complex bereavement disorder (Robinaugh, LeBlanc, Vuletich, & McNally, [2014](#CIT0046)). Although the use of network analyses in psychology is still in its early stages and needs further development (Epskamp, Borsboom, & Fried, [2017](#CIT0019)), interesting studies already lead the direction.

Examples of network models in PTSD research include cross-sectional studies following mass violence identifying 'anger' and 'intrusion' as central symptoms (Sullivan, Smith, Lewis, & Jones, [2018](#CIT0058)), or on victims of a workplace terrorist attack with 'numbness' as core symptom (Birkeland & Heir, [2017](#CIT0005)). Results from a clinical sample of refugees revealed 'emotional cue reactivity' (Spiller et al., [2017](#CIT0051)), while U.S. veteran data identified 'negative emotions' to be central (Armour, Fried, Deserno, Tsai, & Pietrzak, [2017](#CIT0002)). Those results impressively show the heterogeneity of PTSD, with different core aspects emerging for different populations with different traumatic experiences.

However, currently, only few network analyses for longitudinal PTSD data are available (Bryant et al., [2017](#CIT0012); Greene, Gelkopf, Epskamp, & Fried, [2018](#CIT0028)). One model identified a central role of the 'startle response' as a predictor for PTSD symptoms in the following time point (Greene et al., [2018](#CIT0028)). The other found 'intrusive memories' to be central during acute traumatization (Bryant et al., [2017](#CIT0012)).

To the best of our knowledge, data on the role of coping strategies within a network model of PTSD including self-report and endocrine markers are lacking.

3.. From eAssessment to eHealth: CoachPTBS {#S0003}
==========================================

The mobile application CoachPTBS is an e-mental health tool for German-speaking countries that was created based on the success of the U.S. version 'PTSD Coach' (Hoffman et al., [2011](#CIT0030)). CoachPTBS was developed for German military service personnel and their relatives, and has been a joint project by the Universität der Bundeswehr in Munich, the Technische Universität Dresden, and the German Armed Forces Center for Military Mental Health in Berlin. CoachPTBS was released in June 2016 by the head of the German Ministry of Defense. Among information and psychoeducation, the app lists addresses for support and a few short checklists. for screening and subsequently suggesting assistance if necessary. Importantly, like PTSD Coach, the German app also features tools for self-help, mostly alluding to third-wave and mindfulness techniques (Kahl, Winter, & Schweiger, [2012](#CIT0031)). The majority of them represents re-worked and re-implemented versions of the U.S.-American counterpart and encompass exercises like audio-guided breathing, and motivational text to increase activation (e.g. suggesting activities). The user's three highest-rated tools are also assembled in an emergency kit (Kuhn et al., [2018](#CIT0033))

The second interesting aspect of the app for purposes of this study is the 'logbook' specifically implemented for the German CoachPTBS. This category represents an EMA tool in its early stages. Its main feature is a 'momentary assessment' which lets the user choose between six emotional states and comment on it. This feature, too, conveys the idea of the CoachPTBS: The app itself should not be considered a stand-alone intervention but rather a companion tool, by collecting data useful for therapy during the user's everyday life.

CoachPTBS' archetype, the PTSD Coach (Hoffman et al., [2011](#CIT0030)), has already been subject to a feasibility study (Possemato et al., [2016](#CIT0043)). It was found that clinician-supported use of the app resulted in more specialty PTSD care use after intervention (i.e. the app seemed to have motivated or taught people how to acquire further help) and also possibly resulted in greater reductions in PTSD symptoms than in a similar group using PTSD Coach only by themselves, so even self-guided use of the app lead to benefits. These encouraging findings led to the first RCT on the PTSD Coach (Kuhn et al., [2017](#CIT0032)). Participants of this study, after using PTSD Coach for 3 months, had significantly greater improvements in PTSD, as well as depression symptoms and psychosocial functioning, compared to waitlist participants; however, at posttreatment, there were no significant mean differences in outcomes between conditions. The effects were still considered a success since mobile applications -- after initial development and given proper maintenance (cf. Schellong, Lorenz, & Weidner, [2019](#CIT0047)) -- can reach a much broader clientele (Kuhn et al., [2017](#CIT0032)).

These strategies may, at least in part, address long waiting periods for psychotherapy. On average, people in Germany wait for 19.9 weeks on guideline-oriented psychotherapy (BPtK, [2018](#CIT0013)). E-Mental Health tools can bridge this gap, e.g. by focusing patients' attentions to their coping strategies and assessing changes that can be subsequently addressed during therapy.

4.. The proposed study {#S0004}
======================

4.1.. Aim {#S0004-S2001}
---------

The primary goal is to examine CoachPTBS regarding its suitability and effects on individual well-being, symptomatology and coping, the secondary aims are to examine the interplay between PTSD, coping, and HCC. The current study thus combines different facets of longitudinal assessment, i.e. EMA and data collected alongside CoachPTBS, and HCC as a marker for stress-associated long-term endocrine changes in order to increase knowledge about everyday aspects of PTSD and strategies to cope with it. EMA data collection will be implemented in order to further explore the associations between patients' inter- and intra-individual variability of symptom severity, psychoendocrine aberrance and coping strategies. The application CoachPTBS will be employed as a means to possibly improve upon patients' coping techniques while waiting on a trauma-specific psychotherapy and additionally assist in acquisition of momentary data by means of its logbook tools. In order to explore those aims, four groups will be recruited (see [Figure 1](#F0001) and [Table 1](#T0001)): PTSD participants who will use the application CoachPTBS (group A), PTSD participants who will take part in an EMA phase (group B), PTSD participants without any smartphone-based application (group C) and healthy controls (group D).10.1080/20008198.2019.1654064-T0001Table 1.Schedule of assessments.Retrospective assessments\
*(in situ and online)*Ambulatory\
phaseSociodemographic and hair-related dataTrauma and PTSD severityHealth and well-beingCoping strategies and efficacyAfter Ambulatory Phase: Study feedback**AApp Users with PTSD**Manual Usage DiaryPreferred tools, logbooksNumber of uses per tool**BEMA Responders with PTSD**Experiencing of PTSD symptomsApplied coping strategies and efficacy**CControls with PTSD**-**DNon-Traumatized Healthy Control**Aversive emotionsApplied coping strategies and efficacy[^2]

In a first step, insights on unique features of PTSD regarding self-report (symptomatology, emotion regulation, quantity and quality of coping strategies) and HCC are to be expected when compared to the non-traumatized controls (A, B and C vs. D). As a second step, the implementation of EMA leads to expect novel insights into the inter- and intra-individual variability of symptom severity and coping strategies within the PTSD participants (group B) as well as into differences regarding the efficacy and heterogeneity of coping strategies in comparison to the healthy controls (B vs. D). Additionally, the study makes it feasible to analyse possible methodological issues of EMA like reactivity or attrition effects by a comparison of parallel groups of PTSD participants with CoachPTBS, with and without EMA (A vs. B vs. C). Last, but not least, for the purposes of research into CoachPTBS as a primary goal, the study design can yield the beneficial effects of the application regarding symptomatology, quality of life (QoL) and coping strategies. This is acquired by gathering participants' feedback after the CoachPTBS phase (group A), as well as by contrasting group A with the waiting control (A vs. C), and the EMA group (A vs. B). Notwithstanding its overall usefulness, only limited PTSD symptom change occurred through PTSD Coach (Kuhn et al., [2017](#CIT0032)). The present study thusly additionally explores QoL as a more fine-grained measurement. Additionally, the app could enhance coping strategies in a qualitative (i.e. increased diversity in coping strategies) as well as in a quantitative fashion (i.e. increased frequency of use). Since the CoachPTBS works exclusively offline, we can only simulate EMA-acquisition for group A by using digital and manual diary entries to correlate changes with usage. In addition, due to the CoachPTBS' functionality to count and single out the three top-rated tools used we will infer how the app is individually utilized. Moreover, by employing HCC analyses the relationship between patients' perceived benefit of CoachPTBS after 4 weeks and symptom severity at baseline, acquired from biological markers, will become comparable. Changes in stress levels achieved by improving coping skills and possibly reducing symptoms and/or increasing QoL might thus be backed up by biological markers. However, due to the expected limited effect sizes of the CoachPTBS on PTSD, the latter remains an exploratory analysis.

4.2.. Recruitment and inclusion criteria {#S0004-S2002}
----------------------------------------

PTSD participants (*n* = 120) on the waiting list for an in- or outpatient treatment (trauma-specific outpatient clinic, University Hospital in Dresden) will be recruited. Eligible persons will be informed during their treatment-related admission interview by a psychotherapist or via flyers and posters (within the in-/outpatient clinic) about the possibility to participate in the study to bridge waiting time until the start of psychotherapy. Participants are eligible if they fulfil the A criterion (exposure to a traumatic stressor) according to DSM-5 (American Psychiatric Association, [2013](#CIT0001)). The PCL-5 is obligatory for every participant as well (see methods), so inclusion criteria for PTSD (criteria B through E) can be further determined. Exclusion criteria will be insufficient proficiency in German and, because of HCC analyses, hair length shorter than 1 cm, signs of hair loss or baldness, current use of glucocorticoid-containing medication, pregnancy or breast-feeding in women, current shift work or jet lag or smoking more than 15 cigarettes per day. Furthermore, participants should not have any lifetime history of schizophrenia or addictive disorders (self-report). Additionally, age- and gender-matched non-traumatized healthy participants (n = 40) will be recruited via flyers and posters.

These sample sizes of 40 participants per group were considered apt for several reasons. First, because of their intense longitudinal design with many data points generated by each individual, EMA studies bear high statistical power also if the sample sizes are small to medium (Bolger & Laurenceau, [2013](#CIT0007)). Furthermore, n = 40 should be sufficient to depict significant differences between PTSD participants and non-traumatized controls regarding HCC at an α-level of .05 and a statistical power of .95, as existing data yield effect sizes of d = .87 (Steudte et al., [2013](#CIT0054)). Additionally, for EMA studies, dropout rates are rather low (e.g. Moskowitz & Young, [2006](#CIT0036)); with PTSD-focused studies reporting dropout rates between 0% and 8.3% (e.g. Dewey et al., [2015](#CIT0017); Naragon-Gainey, Simpson, Moore, Varra, & Kaysen, [2012](#CIT0038)). Finally, many of the study's central research questions are based on an exploratory approach expected to yield interesting results also in medium-sized samples. In case of dropout, recruitment will continue to reach the planned total sample size.

4.3.. Procedure {#S0004-S2003}
---------------

The study will be conducted in accordance with the latest version of the declaration of Helsinki and has been approved by the local Ethics Committee of the Medical Faculty of the Technische Universität Dresden (EK335082017, EK282062019). After receiving information on the study and giving their informed consent, PTSD participants will be randomly assigned to one out of three PTSD study groups, with the fourth group consisting of age- and gender-matched non-traumatized participants (see [Figure 1](#F0001)). After an in-situ assessment (t0), where self-report data and hair samples will be obtained, participants will follow different further procedures during the ambulatory phase of 4 weeks according to their respective group (see below). All participants, however, will participate in two online assessments regarding symptom severity and coping after 2 weeks (t1) and after 4 weeks (t2), respectively. The final assessment (t3) is similar for all groups: After 6 weeks, an interview and another collection of hair samples will be carried out and participants will be reimbursed depending on their compliance.

The ambulatory phase will proceed as follows: Assisted by the study personnel, group A will receive CoachPTBS for their mobile phone. Throughout 4 weeks of using the application on a daily basis and marking their progress in a diary, they will teach themselves about PTSD and coping strategies. Group B will receive the EMA application movisensXS (movisens GmbH, Karlsruhe, Germany) for their mobile phones, which will be used to complete one questionnaire regarding PTSD symptoms and individual coping strategies each evening on workdays, and additional four assessments on two random days each week. Findings will be compared with the waitlist-control group C, who will neither receive CoachPTBS nor EMA during the ambulatory phase, and also with group D, consisting of healthy non-traumatized controls. Group D will also take part in an EMA assessment regarding coping strategies when confronted with aversive emotions using movisensXS. This is to compare the quality or quantity of coping strategies employed by a healthy versus clinical group.

The study procedure is illustrated in [Figure 1](#F0001). 10.1080/20008198.2019.1654064-F0001Figure 1.Experimental branches, conditions and time line. PTSD = posttraumatic stress disorder. EMA = ecological momentary assessment.

4.4.. Clinical and HCC assessments {#S0004-S2004}
----------------------------------

For the assessment of HCC, hair samples with a diameter of \~3 mm will be taken (at t0 and t3) as close as possible to the scalp from a posterior vertex position (Stalder & Kirschbaum, [2012](#CIT0053)), the area with the proposedly most uniform hair growth rate (Pragst & Balikova, [2006](#CIT0044)). HCC will be analysed in the 1 cm segment most proximal to the scalp. Based on an average hair growth rate of 1 cm per month (Wennig, [2000](#CIT0064)), this segment is considered to reflect cortisol secretion of the previous month prior to hair sampling. The laboratory analyses will be conducted following the published liquid chromatography-tandem mass spectrometry (LC-MS/MS) protocol (Gao et al., [2013](#CIT0025)). This method has been shown to achieve excellent sensitivity, specificity and reliability (intra- and inter-assay CVs between 3.7% and 8.8%) (Gao et al., [2013](#CIT0025)).

Psychological variables like PTSD symptomatology, coping styles and efficacy and subjective well-being will be assessed via three different modes: traditional paper-pencil-based self-report during the in-situ assessments (t0, t3; all groups), retrospective online-based assessments (t1, t2; all groups) and EMA-based self-report during the ambulatory phase (groups B and D). Additionally, for group A, every participant will manually mark their app usage (time spent total and per each of the five main chapters) in a diary. The app itself also collects the number of uses per tool and the three most liked tools. The following table illustrates the data collection plan.

4.5.. Data analyses {#S0004-S2005}
-------------------

Statistical analyses will be conducted partly in an inferential statistical and partly in an exploratory way using SPSS 25.0 for Windows (IBM Corporation, NY, USA). Differences between the study groups regarding baseline symptomatology, coping efficacy and HCC will be examined via t-tests or ANOVAs, respectively.

Analyses regarding the EMA part of the study will be mostly conducted using Multilevel Modelling (Bolger & Laurenceau, [2013](#CIT0007)) because of the hierarchical structure of the data (level 1 = measurement time, level 2 = measurement day, level 3 = participant) and the aptness for dealing with varying time intervals between assessments and missing data. For depicting systematic (i.e. changing with time) or unsystematic (i.e. symptom variability) inter- and intraindividual variations in symptom severity and coping strategies, intraclass correlation coefficients (ICCs) will be used, while associations of symptomatology, coping efficacy and HCC will be analysed using multilevel correlation and regression analyses.

In an exploratory fashion, data acquired through EMA tools (see [Table 1](#T0001)) will be used to create a network model as proposed by Borsboom and Cramer ([2013](#CIT0008)). At its core, analyses will be bivariate partial correlations, suited for dealing with missing values, between symptoms, but also coping strategies, assessed in groups B and D.

4.6.. Discussion {#S0004-S2006}
----------------

To our knowledge, this is the first study to longitudinally assess the interplay between symptomatology, coping strategies, endocrine markers and a self-help tool with the aim of gaining valuable insights in pathogenetic, but also coping strategies regarding PTSD.

Findings may lead to a more exact description regarding the interplay of coping mechanisms and symptomology, whether or not, or under which circumstances (e.g. magnitude of symptomatology or endocrine aberrances), coping skills can be successfully improved through the usage of eHealth and in which parameters this will be reflected (HCC, QoL assessment, symptom changes). Furthermore, it might spark further studies addressing the effect of traumatization versus PTSD, or the exact mechanisms of the proposed bi-directionality between coping and PTSD in a multi-method fashion.

In conclusion, the big strength of the presented study is the multimodal approach, combining traditional, online and EMA self-report measures with HCC as a biomarker of traumatic stress and the mobile application CoachPTBS as a possible novel mHealth tool.
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